International Journal of Endocrinology and Metabolism

Published by: Kowsar

Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients?

Antonino Lasco 1 , * , Antonino Catalano 1 and Nancy Morabito 1
Authors Information
1 Department of Internal Medicine, University of Messina, 98125 Messina, Italy
Article information
  • International Journal of Endocrinology and Metabolism: September 01, 2012, 10 (4); 634-635
  • Published Online: September 29, 2012
  • Article Type: Letter
  • Received: May 5, 2012
  • Revised: May 9, 2012
  • Accepted: May 9, 2012
  • DOI: 10.5812/ijem.6239

To Cite: Lasco A, Catalano A, Morabito N. Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients?, Int J Endocrinol Metab. 2012 ;10(4):634-635. doi: 10.5812/ijem.6239.

Copyright © 2012, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2006; 70(7): 1358-66[DOI][PubMed]
  • 2. Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007; 22(9): 1317-28[DOI][PubMed]
  • 3. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999; 282(7): 637-45[DOI]
  • 4. Saito O, Saito T, Asakura S, Akimoto T, Inoue M, Ando Y, et al. Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients With Type 2 Diabetes. Int J Endocrinol Metab. 2012; 10(2): 464-9[DOI]
  • 5. Lasco A, Gaudio A, Morabito N, Previti M, Mileto A, Frisina N, et al. Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women. Diabetologia. 2004; 47(3): 571-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments